These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38731883)

  • 1. PKIB, a Novel Target for Cancer Therapy.
    Musket A; Moorman JP; Zhang J; Jiang Y
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on correlation between PKIB and pAkt expression in breast cancer tissues.
    Zhang JB; Song W; Wang YY; Liu MG; Sun MM; Liu H
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1264-1269. PubMed ID: 28387904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
    Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
    Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of cAMP-Dependent Protein Kinase Inhibitor-b Promotes Preeclampsia by Decreasing Phosphorylated Akt.
    Liu C; Wang H; Yang M; Liang Y; Jiang L; Sun S; Fan S
    Reprod Sci; 2021 Jan; 28(1):178-185. PubMed ID: 32676926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.
    Dabanaka K; Chung S; Nakagawa H; Nakamura Y; Okabayashi T; Sugimoto T; Hanazaki K; Furihata M
    Med Mol Morphol; 2012 Dec; 45(4):229-33. PubMed ID: 23224602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of cAMP-dependent protein kinase inhibitor beta in colorectal carcinoma and its clinical significance].
    Wang HW; Duan ZJ; Hu SS; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jun; 37(6):744-749. PubMed ID: 28669946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKIB promotes cell proliferation and the invasion-metastasis cascade through the PI3K/Akt pathway in NSCLC cells.
    Dou P; Zhang D; Cheng Z; Zhou G; Zhang L
    Exp Biol Med (Maywood); 2016 Nov; 241(17):1911-1918. PubMed ID: 27325557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A as a biological target in cancer therapy.
    Naviglio S; Caraglia M; Abbruzzese A; Chiosi E; Di Gesto D; Marra M; Romano M; Sorrentino A; Sorvillo L; Spina A; Illiano G
    Expert Opin Ther Targets; 2009 Jan; 13(1):83-92. PubMed ID: 19063708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.
    Naviglio S; Di Gesto D; Illiano F; Chiosi E; Giordano A; Illiano G; Spina A
    J Cell Physiol; 2010 Nov; 225(3):801-9. PubMed ID: 20589829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy.
    Creevey L; Bleach R; Madden SF; Toomey S; Bane FT; Varešlija D; Hill AD; Young LS; McIlroy M
    Mol Cancer Ther; 2019 Oct; 18(10):1731-1743. PubMed ID: 31289138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase inhibitor β enhances the constitutive activity of G-protein-coupled zinc receptor GPR39.
    Kovacs Z; Schacht T; Herrmann AK; Albrecht P; Lefkimmiatis K; Methner A
    Biochem J; 2014 Aug; 462(1):125-32. PubMed ID: 24869658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
    Bidwell P; Joh K; Leaver HA; Rizzo MT
    Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.
    Lucchi S; Calebiro D; de Filippis T; Grassi ES; Borghi MO; Persani L
    PLoS One; 2011; 6(6):e20785. PubMed ID: 21695205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.
    Cass LA; Summers SA; Prendergast GV; Backer JM; Birnbaum MJ; Meinkoth JL
    Mol Cell Biol; 1999 Sep; 19(9):5882-91. PubMed ID: 10454535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation.
    Mei FC; Qiao J; Tsygankova OM; Meinkoth JL; Quilliam LA; Cheng X
    J Biol Chem; 2002 Mar; 277(13):11497-504. PubMed ID: 11801596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cAMP-dependent protein kinase pathway as therapeutic target: possibilities and pitfalls.
    Kleppe R; Krakstad C; Selheim F; Kopperud R; Døskeland SO
    Curr Top Med Chem; 2011; 11(11):1393-405. PubMed ID: 21513494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous protein kinase inhibitor gamma terminates immediate-early gene expression induced by cAMP-dependent protein kinase (PKA) signaling: termination depends on PKA inactivation rather than PKA export from the nucleus.
    Chen X; Dai JC; Orellana SA; Greenfield EM
    J Biol Chem; 2005 Jan; 280(4):2700-7. PubMed ID: 15557275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway.
    Schernthaner-Reiter MH; Trivellin G; Stratakis CA
    Mol Cell Endocrinol; 2020 Jan; 499():110607. PubMed ID: 31586652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.